|
|
|
|
Scientists at College of Pharmacy, Department of Pharmaceutical Technology detail research in pharmaceuticals
- (NewsRx.com) -- Current study results from the report, 'Development of microsponges for topical delivery of mupirocin,' have been published (see also Pharmaceuticals).According to recent research published in...
|
|
|
NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
Milestone Payment from Alcon and Initial Payments from New Galderma Collaboration Resulted in Positive Cash-Flow for the Quarter EMERYVILLE, Calif., May 18 /PRNewswire-FirstCall/ -- NovaBay Pharmaceuticals, Inc.(NYSE Amex: NBY), a mid...
|
|
|
NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
Related: Alcon Inc., Milestone Payment from Alcon and Initial Payments from New Galderma Collaboration Resulted in Positive Cash-Flow for the Quarter EMERYVILLE, Calif., May 18 /PRNewswire-FirstCall/ -- (NYSE Amex: NBY), a mid-stage...
|
|
|
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
FAIRFIELD, N.J., April 27 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company launched Centany(R) (mupirocin ointment, 2%) and Uramaxin(TM) (20% Urea) Foam to its core Dermatology and Podiatry physician audiences.
|
|
|
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
FAIRFIELD, N.J., April 27 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company launched Centany (mupirocin ointment, 2%) and Uramaxin(TM) (20% Urea) Foam to its core Dermatology and Podiatry physician audiences.
|
|
|
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
FAIRFIELD, N.J., April 27 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company launched Centany(R) (mupirocin ointment, 2%) and Uramaxin(TM) (20% Urea) Foam to its core Dermatology and Podiatry physician audiences.
|
|
|
Medimetriks Pharmaceuticals Launches Two New Prescription Brands
FAIRFIELD, N.J., April 27 /PRNewswire/ -- Medimetriks Pharmaceuticals announced today that the Company launched Centany(R) (mupirocin ointment, 2%) and Uramaxin(TM) (20% Urea) Foam to its core Dermatology and Podiatry physician audiences.
|
|
|
Glaxo to buy Stiefel Labs for $2.9 billion
GlaxoSmithKline P.L.C.said yesterday that it would pay $2.9 billion in cash to buy Florida dermatology business Stiefel Laboratories Inc., the second sizeable deal announced by the London drugmaker in less than a week. Stiefel is a...
|
